Great West Life Assurance CO Avrobio, Inc. Transaction History

Great West Life Assurance CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $10,943 - $19,190	-3,172 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $18,402 - $33,697	1,746 Added 122.44%	3,172 $40,000
Q3 2020 Nov 17, 2020	SELL	$12.99 - $19.41 $150,164 - $224,379	-11,560 Reduced 89.02%	1,426 $18,000
Q3 2020 Nov 13, 2020	BUY	$12.99 - $19.41 $150,164 - $224,379	11,560 Added 810.66%	12,986 $169,000
Q4 2019 Feb 11, 2020	BUY	$13.05 - $21.88 $18,609 - $31,200	1,426 New	1,426 $28,000
Q3 2019 Oct 25, 2019	SELL	$14.12 - $23.44 $29,835 - $49,528	-2,113 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$15.43 - $32.7 $32,603 - $69,095	2,113 New	2,113 $34,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.